Unannounced · 343 daysFiled 9 October 2025
EyeMacular Regeneration, Inc. has sold $2M so far
EyeMacular Regeneration, Inc., a biotech company based in St. Paul, MN, has sold $2M so far in its equity round, according to a filing dated 9 October 2025.
No public announcement found as of 15 September 2026, 343 days after the filing.
- Filed
- 9 October 2025
- Round
- Equity round (amended filing)
- Amount sold
- $2M
- Offering size
- $6M
- Investors so far
- 12
- Based in
- St. Paul, MN
- Website
- eyemacregen.com
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 18% of the 1,404 tracked raises with an amount filed in 2025, and than 12% of the 112 in biotech.
EyeMacular Regeneration, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 9 Oct 2025 | Amended filing | $2M | This raise |
More with Techstars Boston on the board
- Ognomy Inc.$14.9M
- 3AM Innovations, Inc$750K
- CHONEX, Inc.$3.45M
- Partake Foods, Inc.$20.8M
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.